Aller au contenu

ESMO CONGRESS 2022

9 Septembre 2022 · 5 joursParis, FranceOncologieAnglais
ESMO CONGRESS 2022
Paris

À propos de ce congrès

The ESMO Congress is the most influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. ESMO Congress 2022 will again present the very latest advances in the treatment of cancer and offer an excellent educational programme, with a wealth of opportunities for exchange of ideas among delegates.

MEDFLIXS couvrira les temps forts de ce congrès sous forme d'interviews vidéo et de best-of disponibles pour les professionnels de santé inscrits.

Vidéos de ce congrès

Toni Choueiri · Highlights on cabozantinib with nivo and ipi for intermediate_poor risk adv. RCC_COSMIC-313
Lancer la vidéo · Toni Choueiri · Highlights on cabozantinib with nivo and ipi for intermediate_poor risk adv. RCC_COSMIC-313Inscription gratuite requise pour lancer la lecture

Toni Choueiri · 00:02:55

Chris Parker · Highlights on ADT duration with post-operative radiotherapy in prostate cancer_RADICALS-HD
Lancer la vidéo · Chris Parker · Highlights on ADT duration with post-operative radiotherapy in prostate cancer_RADICALS-HDInscription gratuite requise pour lancer la lecture

Chris Parker · 02:20:00

Sio Ming LEE · Highlights on first-line atezolizumab in NSCLC not eligible for platinum_ The IPSOS study
Lancer la vidéo · Sio Ming LEE · Highlights on first-line atezolizumab in NSCLC not eligible for platinum_ The IPSOS studyInscription gratuite requise pour lancer la lecture

Sio Ming LEE · 00:02:29

Melissa JOHNSON · Highlights on Sotorasib in NSCLC with KRAS G12C mutation_ The CodeBreaK 200 study
Lancer la vidéo · Melissa JOHNSON · Highlights on Sotorasib in NSCLC with KRAS G12C mutation_ The CodeBreaK 200 studyInscription gratuite requise pour lancer la lecture

Melissa JOHNSON · 00:02:34

Sapna PATEL · Highlights on neoadj. vs adjuvant pembrolizumab in resected stage III-IV melanoma_SWOG S1801
Lancer la vidéo · Sapna PATEL · Highlights on neoadj. vs adjuvant pembrolizumab in resected stage III-IV melanoma_SWOG S1801Inscription gratuite requise pour lancer la lecture

Sapna PATEL · 00:02:21

Arvind DASARI · Highlights on the efficacy and safety of fruquintinib in refractory mCRC_ The FRESCO-2 study
Lancer la vidéo · Arvind DASARI · Highlights on the efficacy and safety of fruquintinib in refractory mCRC_ The FRESCO-2 studyInscription gratuite requise pour lancer la lecture

Arvind DASARI · 00:03:34

Jean-Pascal MACHIELS · Highlights on pembrolizumab with CRT in locally advanced HNSCC_ The KEYNOTE-412 study
Lancer la vidéo · Jean-Pascal MACHIELS · Highlights on pembrolizumab with CRT in locally advanced HNSCC_ The KEYNOTE-412 studyInscription gratuite requise pour lancer la lecture

Jean-Pascal MACHIELS · 00:02:16